ViGenCell

ViGenCell Gross Margin

The Gross Margin of ViGenCell (308080.KQ) as of Oct 19, 2026 is 48.79 %. In the previous year, Gross Margin was 4.26 % — a change of 1,045.25% (higher).

Gross Margin

48.79 %

YoY

1,045.25%

Last updated:

Gross Margin of ViGenCell is 2025 48.79 % . Gross Margin of ViGenCell was 2024 4.26 % . It decreases by 1,045.25% higher compared to the previous year.

ViGenCell's gross margin stands at 48.8%, down from 100.0% several years earlier.

The ViGenCell Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2019
100.00 KRW
Jan 1, 2024
4.26 KRW
Jan 1, 2025
48.79 KRW
The ViGenCell Gross Margin history
YEARGross MarginYoY
48.79 %+1,045.25%
4.26 %-95.74%
100.00 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ViGenCell Stock analysis

What does ViGenCell do? ViGenCell Inc is a biotechnology company based in Seoul, South Korea, operating within the Health Care sector. The company has 80 employees and completed its initial public offering (IPO) on August 25, 2021. ViGenCell focuses on research and development in natural science and engineering, with a particular emphasis on cell therapy technologies. The company develops and manufactures immuno-cancer cell therapy products and immunosuppressive cell therapy products. It also provides the Vitier platform, which is an antigen-specific killing T cell treatment, the Viranger platform for gamma delta T cell gene therapy, and the Vimedier platform-based technology for myeloid suppressor cell therapy derived from umbilical cord blood. ViGenCell is engaged in the research and development of new drugs targeting conditions such as acute myeloid leukemia (AML) and glioblastoma. The company's website is https://www.vigencell.com/. ViGenCell Inc is listed on the Korean stock market under the ticker 308080.KQ and has the ISIN KR7308080001. The company's headquarters are located in Seoul, South Korea. ViGenCell is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ViGenCell stock

Gross Margin of ViGenCell is 48.79 % in 2025.

Gross Margin of ViGenCell changed from 4.26 % to 48.79 %, representing a 1,045.25% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin ViGenCell since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's ViGenCell with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — ViGenCell

All Key Metrics — ViGenCell